These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17212202)

  • 1. [Arterial hypertension in patients on long-term haemodialysis].
    Pavlović D; Heinrich B; Germin-Petrović D; Pavlović N
    Lijec Vjesn; 2006; 128(11-12):381-4. PubMed ID: 17212202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey.
    Tkaczyk M; Nowicki M; Bałasz-Chmielewska I; Boguszewska-Baçzkowska H; Drozdz D; Kołłataj B; Jarmoliński T; Jobs K; Kiliś-Pstrusińska K; Leszczyńska B; Makulska I; Runowski D; Stankiewicz R; Szczepańska M; Wierciński R; Grenda R; Kanik A; Pietrzyk JA; Roszkowska-Blaim M; Szprynger K; Zachwieja J; Zajaczkowska MM; Zoch-Zwierz W; Zwolińska D; Zurowska A
    Nephrol Dial Transplant; 2006 Mar; 21(3):736-42. PubMed ID: 16303782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
    Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
    Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihypertensive therapy in elderly patients].
    Schrader J; Dominiak P
    Z Arztl Fortbild (Jena); 1995 Dec; 89(8):825-32. PubMed ID: 8850113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in dialysis: pathophysiology and treatment.
    D'Amico M; Locatelli F
    J Nephrol; 2002; 15(4):438-45. PubMed ID: 12243377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of antihypertensive drugs in hypertensive patients on renal replacement therapy (RRT).
    Zazgornik J; Biesenbach G; Forstenlehner M; Stummvoll K
    Clin Nephrol; 1997 Dec; 48(6):337-40. PubMed ID: 9438090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Society of Nephrology, Computer Technology Commission. Dialysis computer program. VI. - Survival and risk factors].
    Degoulet P; Reach I; Rozenbaum W; Aime F; Devries C; Berger C; Rojas P; Jacobs C; Legrain M
    J Urol Nephrol (Paris); 1979 Dec; 85(12):909-62. PubMed ID: 554877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing hypertension control in hemodialysis patients: a proposed management strategy.
    Tarrass F; Addou K; Benjelloun M; Zamd M; Medkouri G; Hachim K; Benghanem MG; Ramdani B
    Saudi J Kidney Dis Transpl; 2007 Sep; 18(3):355-60. PubMed ID: 17679745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N; Martins S; Belo A; Fiuza M;
    Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effect of low calcium dialysis.
    Katzir Z; Michlin A; Boaz M; Biro A; Smetana S
    Isr Med Assoc J; 2005 Nov; 7(11):704-7. PubMed ID: 16308992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade.
    Campistol JM; Romero R; Paul J; Gutiérrez-Dalmau A
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii62-6. PubMed ID: 15192139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension in hemodialysis: prevalence and associated factors in Catalonia. The PRESDIAL study].
    Poch E; Martinez X; Rodrigo JA; Tovar JL;
    Nefrologia; 2006; 26(5):564-72. PubMed ID: 17117899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Queen Mary Utilization of Antihypertensive Drugs Study: side-effects of antihypertensive drugs.
    Cheung BM; Wong YL; Lau CP
    J Clin Pharm Ther; 2005 Aug; 30(4):391-9. PubMed ID: 15985053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.